Mark Basik
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 40
- Breast Cancer Treatment Studies 34
- Oncology top 0.5%
- HER2/EGFR in Cancer Research 16
- Cancer Cells and Metastasis 10
- Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 16
- Genetic factors in colorectal cancer 14
- Molecular Biology top 2%
- Immunology top 5%
-
- BRCA gene mutations in cancer 10
-
- Advanced Proteomics Techniques and Applications 9
- Co-authors
- Marguerite BuchananAdriana Aguilar‐MahechaAbdel HoseinJeffrey L. WranaValbona LugaElaine ChiuAlicia Viloria‐PetitLiang Zhang
- Journals
- Journal of Clinical Oncology (14 papers)Annals of Surgical Oncology (11 papers)Cancer Research (10 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Mark Basik
135 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Cancer Research 2.9k
- Oncology 2.8k
- Pathology and Forensic Medicine 1.3k
- Molecular Biology 3.5k
- Immunology 774
Countries citing papers authored by Mark Basik
This map shows the geographic impact of Mark Basik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Basik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Basik more than expected).
Fields of papers citing papers by Mark Basik
This network shows the impact of papers produced by Mark Basik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Basik. The network helps show where Mark Basik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Basik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 41 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 10 | |
| 9 | 2019 | 34 | |
| 10 | 2019 | 13 | |
| 11 | 2019 | 48 | |
| 12 | 2018 | 3 | |
| 13 | 2017 | 40 | |
| 14 | 2015 | 41 | |
| 15 | 2012 | 93 | |
| 16 | 2012 | 39 | |
| 17 | 2010 | 67 | |
| 18 | 2009 | 51 | |
| 19 | 2009 | 296 | |
| 20 | Expression of epiregulin and amphiregulin and K-RAS mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab (Erbitux ®) | 2007 | 3 |
About Mark Basik
Mark Basik is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Immunology and Allergy and Genetics, having authored 142 papers that have together received 7.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (40 papers), Breast Cancer Treatment Studies (34 papers), Breast Lesions and Carcinomas (16 papers), HER2/EGFR in Cancer Research (16 papers), Genetic factors in colorectal cancer (14 papers), BRCA gene mutations in cancer (10 papers), Cancer Cells and Metastasis (10 papers) and Advanced Proteomics Techniques and Applications (9 papers). The work is most often cited by research in Cancer Research (2.9k citations), Oncology (2.8k citations), Pathology and Forensic Medicine (1.3k citations), Molecular Biology (3.5k citations) and Immunology (774 citations). Mark Basik has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Marguerite Buchanan, Adriana Aguilar‐Mahecha, Abdel Hosein, Jeffrey L. Wrana, Valbona Luga, Elaine Chiu, Alicia Viloria‐Petit, Liang Zhang, Abiodun A. Ogunjimi and Saima Hassan. Their work appears in journals such as Journal of Clinical Oncology, Annals of Surgical Oncology, Cancer Research, European Journal of Surgical Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.